Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Bullboard Posts
Post by kmuchaon Jul 17, 2019 10:30am
188 Views
Post# 29929284

I'm Out

I'm OutSold off 90% of my shares today, kept 30,000 in case I'm wrong. I initially got in at .165....sold along the way a bit, made some money, but not as much as I should have.

I can't stay with PMN anymore.

I'm a super positive and patient guy, but I can't just keep waiting for nothing to happen.

They just talk and talk and talk, present, present, present...but nothing happens. Just no action...literally they just got to conferences to talk....but nothing has come from it int he 3 years I've been invested. Why would something all of a sudden come now if it hasn't in the past 2-3 years?

One of the last straws for me was the latest private placement....I think they only raised 1.1mil....considerably less than all other raises.

They say they aren't taking any wages until a deal happens...prove it.

I love the science, but at this point it's just talk. If this thing gets to the low teens or into the pennies, which is a good possible if it continues to trend down...I'll consider getting a few more shares, but at this point I need to wash my hands and walk away (except for the shares I am keeping for now).

I hope this turns out for everyone in here.
Bullboard Posts